Accreditation


Upon completion of these educational activities,
participants will be able to:

  1. Describe key concepts in the pathophysiology of severe asthma.
  2. Analyze recent clinical data of current and emerging targeted therapies and potential biomarkers for severe asthma.
  3. Select personalized treatment approaches for severe asthma best suited to various phenotypes and endotypes.

CME COURSES

This online program includes three individual learning activities featuring leading experts in the field of severe asthma. The intended audience for this course includes: Pulmonologists, Allergists, Primary Care Physicians and other health care professionals who treat patients with severe asthma.

Module 1: Pathophysiology

CME Credit: .50

Learn about the key concepts in the pathophysiology of severe asthma.

Module 2: Current and Emerging Asthma Therapies

CME Credit: .50

Learn about recent clinical data of current and emerging therapies and potential biomarkers for severe asthma.

Module 3: Roundtable Discussion on Personalized Treatment Approaches

CME Credit: .75

We pull together information from the first two modules using a multidisciplinary roundtable discussion with key opinion leaders.

Target Audience

Allergists, pulmonologists, primary care physicians, pediatricians, physician assistants, advanced practice nurses and other health care providers involved in the treatment of patients with severe asthma will be targeted for this activity in support of multidisciplinary learning.

Accreditation Statement

National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

National Jewish Health designates each enduring material module for a maximum of .5 AMA PRA Category 1 Credits™ for each program. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Support

This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, and Sanofi Genzyme and Regeneron Pharmaceuticals.

Requirements for Successful Completion

In order to receive credit, participants must complete the pre-test, view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of credit are awarded upon successful completion of the post-test with a passing score of ≥ 70%, and evaluation form.

Faculty & Disclosure Information

In accordance with ACCME requirements, National Jewish Health has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Anthony N. Gerber, MD, PhD

Associate Professor
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
Department of Biomedical Research
National Jewish Health, Denver, CO

Dr. Gerber discloses that he is a Consultant for Revon Systems.

Flavia Cecilia Lega Hoyte, MD

Assistant Professor
Director, Allergy and Clinical Immunology Fellowship
Department of Medicine
Division of Allergy and Clinical Immunology
National Jewish Health, Denver, CO

Dr. Hoyte has no financial interests/relationships or affiliations in relation to this activity

Michael E. Wechsler, MD, MMSc

Co-Director, The Cohen Family Asthma Institute
Professor
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health, Denver, CO

Dr. Wechsler discloses that he is a Consultant for AstraZeneca, Boston Scientific, Genentech/Novartis, Patara, Sanofi/Regeneron, Teva, and Vitaeris/Vectura

Reviewers

Tristan J. Huie, MD
Assistant Professor
Division of Pulmonary, Critical Care and Sleep Medicine
Department of Medicine
National Jewish Health, Denver, CO

Dr. Huie discloses that he is on an Advisory Board for Boehringer Ingelheim as well as a Consultant for Boehringer Ingelheim, Genentech and Paraxel.  He also discloses that he is an Investigator for Boehringer Ingelheim, Genentech and Promedior.

 

Andrea Harshman, MHA, CHCP, CMP-HC
Director, Office of Professional Education
National Jewish Health, Denver, CO

Ms. Harshman has no financial interests/relationships or affiliations in relation to this activity.

Planner

Mandy Comeau
Professional Education Programs Coordinator, Office of Professional Education
National Jewish Health, Denver, CO

Ms. Comeau has no financial interests/relationships or affiliations in relation to this activity.

CME Disclaimer

National Jewish Health (”NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.

By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.

Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.

Hardware/Software Requirements

To access these activities, users will need:
A computer with an Internet connection, Adobe Flash Player and/or an HTML5 capable browser for video playback

Internet Explorer 10+
Firefox 8+
Safari 6+
or any other W3C standards
compliant browser

Adobe Acrobat Reader

We recommend a device that has a display capability of 1024 x 768 or better
Mobile devices are not recommended for this activity

Contact Information

For questions regarding this activity, please contact the Office of Professional Education at National Jewish Health:
303.398.1000 or proed@njhealth.org.

National Jewish Health
1400 Jackson Street
Denver, CO 80206
© 2017 National Jewish Health


Grant Statement
This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, and Sanofi Genzyme and Regeneron Pharmaceuticals.